Patients’ Trajectory With Lung Cancer From Treatment Initiation to End-Of-Life: A Retrospective Cohort Study Using Claims Data in Japan
Introduction This study aimed to describe the course of patients with lung cancer from treatment initiation to end-of-life. Methods This retrospective cohort study used Claims Data from the National Health Insurance and Advanced Elderly Medical Service System. We analyzed data from patients newly di...
Saved in:
| Main Authors: | Yuri Ogura MD, Masahiro Iwasaku MD, PhD, Mami Ishida MD, PhD, Yuki Katayama MD, PhD, Naoya Nishioka MD, PhD, Kenji Morimoto MD, PhD, Chie Yamamoto MD, Shinsaku Tokuda MD, PhD, Yoshiko Kaneko MD, PhD, Tadaaki Yamada MD, PhD, Hideya Yamazaki MD, PhD, Masayoshi Inoue MD, PhD, Hiroshi Ikai MD, PhD, Koichi Takayama MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748241305234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01) -
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01) -
Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma
by: Yumi Ishiyama, MD, et al.
Published: (2025-08-01) -
Spontaneous cervical and mediastinal hematoma due to rupture of inferior thyroid artery
by: Takayuki Yamada, MD, PhD, et al.
Published: (2025-02-01) -
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
by: Yoshihito Kogure, MD, PhD, et al.
Published: (2025-03-01)